Events|

SHL to showcase innovative solutions for high volume drug delivery at Pharmapack Europe

Press Release 201901 Pharmapack 2019

SHL Group is looking forward to exhibiting at the 2019 Pharmapack, Europe’s dedicated pharmaceutical packaging and drug delivery event from February 6-7 in Paris, France.

At the center of this year’s exhibition is Molly® 2.25, SHL’s high volume variation of its classic Molly® autoinjector, designed with a preconfigured technology to help pharmaceutical companies minimize initial equipment investments and speed up development timelines. Boasting an intuitive design that meets a variety of patient handling profiles, Molly® 2.25 supports the trend for injection volumes in the 1-2.25mL range to meet the increasing need for the simple delivery of larger doses. SHL is also looking forward the market introduction of the first drug product based on the Molly® 2.25 program.

Another highlight at this year’s event is the range of autoinjectors built with SHL’s Needle Isolation Technology (NIT®). This proprietary technology allows cartridge-based injection devices to be built as easy-to-use autoinjectors with permanently hidden needles. “The NIT® is a true problem solver because cartridges not only open up a world of opportunities for pharma companies, it also offers patients a safe and intuitive experience without sacrificing usability,” said Magnus Fastmarken, SHL’s global director of marketing.

This year, SHL is again pairing up with Innovation Zed to present InsulCheck at Pharmapack’s Innovation Gallery. This year’s display, InsulCheck Connect, is a smart pen injector add-on that displays the time elapsed since last injection. It can be connected to 3rd party service applications to track insulin injection. InsulCheck Connect is compatible with a *variety of existing insulin injection pens on the market and can be customized to support other pen injector projects.

Visitors are invited to explore SHL’s innovative injectable drug delivery solutions at Stand B44 at the Paris Expo Porte de Versailles.

*For full list of pen injectors compatible with InsulCheck Connect, please refer to the company website, or contact us at info@shl-group.com.)

About SHL Medical

As a world-leading solutions provider of advanced drug delivery systems, SHL Medical is the partner of choice for many leading pharma and biotech companies. Driven by our company purpose – Enabling Patients’ Independence – we offer patient-centric solutions for the design, development, and manufacturing of autoinjectors, pen injectors, as well as innovative specialty delivery systems for large-volume and high-viscosity formulations. We also offer final assembly, labeling, and packaging solutions for our drug delivery systems.  ​

In response to the rising trend in home therapy, SHL has increased developmental work in the digital healthcare sector to help improve the drug delivery ecosystem

Located across Switzerland, Taiwan, Sweden, and the US, our global team of experts collaborate seamlessly as one team in utilizing our comprehensive in-house manufacturing capabilities. Our solutions offer customization and optimization for each project while proactively weaving sustainability-driven measures into our designs and processes to contribute to a cleaner earth.​

For additional information, visit www.shl-medical.com

Media contact: info@shl-medical.com

Share:

Related News